Systematic Analysis of Transrectal Prostate Biopsies Using an Ink Method and Specific Histopathologic Protocol: A Prospective Study by Parada, David et al.
Hindawi Publishing Corporation
Prostate Cancer
Volume 2011, Article ID 380249, 3 pages
doi:10.1155/2011/380249
Research Article
SystematicAnalysis ofTransrectal ProstateBiopsies
Usingan InkMethod andSpeciﬁc Histopathologic Protocol:
AP r o spe c ti v eS tu d y
David Parada,1,2 Nahum Calvo,3,4 Karla Pe˜ na,1,2 Vanesa Morente,1,2 Rosana Queralt,1,2
PilarHernandez,5 and FrancescRiu1,2
1Servei de Patologia i, Hospital Universitari Sant Joan de Reus, Tarragona 43206, Reus, Spain
2Institut d’Investigaci´ oS a n i t` aria Pere Virgili (IISPV), Universitat Rovira i Virgili, Tarragona, Reus, Spain
3CRC Corporaci´ on Sanit` aria, Tarragona, Reus, Spain
4Servei de Radiologia i, Hospital Universitari Sant Joan de Reus, Tarragona, 43206 Reus, Spain
5Epidemiolog´ ıa, Estad´ ıstica y Bioinform´ atica, Institut d’Investigaci´ oS a n i t` aria Pere Virgili (IISPV),
Tarragona, Reus, Spain
Correspondence should be addressed to David Parada, dparada@grupsagessa.com
Received 14 February 2011; Accepted 11 April 2011
Academic Editor: Kenneth A. Iczkowski
Copyright © 2011 David Parada et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. Transrectal prostate biopsy is the standard protocol for the screening for prostate cancer. It helps to locate prostatic
adenocarcinoma and plan treatment. However, the increasing number of prostate biopsies leads to considerably greater costs
for the pathology laboratories. In this study, we compare the traditional method with an ink method in combination with a
systematic histopathologic protocol. Methods. Two hundred consecutive transrectal prostate biopsy specimens were received from
the radiology department. They were separated into two groups: one hundred were processed as six diﬀerent specimens in the
usual manner. The other one hundred were submitted in six containers, the apex, base, and middle section of which were stained
diﬀerent colours. The samples subject to the ink method were embedded in paraﬃn and placed in two cassettes which were
sectioned using a speciﬁc protocol. Results. The comparative study of the nonink and ink methods for histopathologic diagnosis
showed no statistical diﬀerences as far as diagnostic categories were concerned (P value <. 005). The number of PIN diagnoses
increased when the ink method was used, but no statistical diﬀerences were found. The ink method led to a cost reduction of
48.86%. Conclusions. Our ink method combined with a speciﬁc histopathologic protocol provided the same diagnostic quality,
tumor location informationas the traditional method, and lower pathology expenses.
1.Introduction
Biopsy specimens need to be appropriately histologically
sampled if diagnoses are to be correct and complete.
Inadequate sampling results in less informative diagnoses
and misdiagnoses, while oversampling leads to wasted time
and expenses. These issues are especially relevant to prostate
needle biopsies because they comprise a signiﬁcant portion
of anatomic pathology practice and contain clinically rele-
vant features that are often microscopically focal.
Systematic parasagittal sextant biopsy has been the
standard protocol for many years in screening for prostate
cancer [1–3], but this “standard method” has been modiﬁed
to increase the probability of diagnosing prostatic adeno-
carcinoma and to allow for variation in the sampling and
submission of prostate biopsies [4]. To improve the cancer
detection rate, many prostate biopsy schemes have been
extended to ten, twelve, or more cores per patient [5].
The increase in the number of prostate biopsies creates
considerable extra expense for the pathology laboratory:
consumables and work for technicians and pathologists’
time. In this study, we analyzed the eﬀectiveness of using an
ink method for transrectal prostate biopsy combined with
a histopathologic protocol that was similar to the routine
histopathological method.2 Prostate Cancer
2.Materialsand Methods
2.1. Tissue Processing. For this study, radiologists submitted
two hundred consecutive transrectal prostate biopsy spec-
imens, from September 2009 to January 2010. Specimens
were separated into two groups of one hundred samples
each: the nonink group and the ink group. The nonink
specimens were processed as six diﬀerent specimens with
one or two tissue cores. The apex and base were green and
blue, respectively, while the middle section was not inked.
Theﬁrst onehundredwereeachembeddedin paraﬃnblocks
and sectioned until full-face tissue was observed, as usual.
Three sections were obtained for histological examination.
One slide of nonink material was given to the pathologist’s
staﬀ. If they considered it to be necessary, they were
free to obtain additional H-E (levels or a new H-E) and
immunohistochemical studies.
The paraﬃn-embedded samples from the ink method
were placed in two casettes (right and left) with at least
six cylinders of material. The two blocks were sectioned
using the following protocol. Level 1: 1 H-E + 3 unstained
intervening slides for immunohistochemistry study +15
microns sections. Level 2: 1 H-E + 3 unstained intervening
slides for immunohistochemistry study +15 microns sec-
tions. Level 3: 1 H-E + 3 unstained intervening slides for
immunohistochemistry. Unstained sections were subject to
immunohistochemical when it was required. The nonused
unstained slides were discarded once a diagnosis had been
made.
2.2. Histopathologic Review. The study focused on a series
of specimens from 200 consecutive 18 gauge transrectal
prostate biopsies that were performed at the Sant Joan Uni-
versity Hospital between 1 September, 2009 and 1 January,
2010. The diagnostic categories were, (1) benign prostate
tissue, (2) prostatic intraepithelial neoplasia (high-grade
PIN), (3) atypical glands suspicious for adenocarcinoma,
and (4) prostatic adenocarcinoma. In each category, we
evaluated the number of paraﬃn blocks, number of levels,
and number of immunohistochemical studies.
2.3.Statistical Analysis. EPIDATsoftwarewasusedtoanalyze
the diﬀerences between the two protocols. A P value less
than .05 was considered signiﬁcant.
3.Results
3.1. Nonink Method. The histopathologic diagnoses in 100
consecutive cases of transrectal prostate biopsies were the
following: benign prostatic tissue 56%, PIN 4%, atypical
glands 3%, and adenocarcinoma 37%. A total of 600 initial
histological examinations were carried out in each case,
and 563 additional levels were required before a diagno-
sis could be made. Additionally, 66 immunohistochemical
studies were performed to conﬁrm the ﬁnal diagnosis.
The total number of H-E, level, and immunohistochemical
studies was 1229. The total number of paraﬃn blocks
Table 1:Diagnosticproportiondiﬀerences between noninkanding
groups.
% nonink % ink Diﬀerence %
P value
Adenocarcinoma 37.0 34.0 .77
PIN 4.0 8.0 .37
Atypical glands 3.0 4.0 1.00
Benign 56.0 54.0 .89
P value <. 005 for diﬀerences among all categories.
Table 2: Comparative use of resources between nonink and ink
groups.
Number % nonink % ink Diﬀerence %
P value
H-E levels 863 65.2 34.8 .0001
Immunohistochemistry 120 55.0 45.0 .16
Block 800 75.0 25.0 .0001
Levels + immunohist. 983 64.0 36.0 .0001
P value <. 005 for diﬀerence among all categories.
Table 3: Relation of the use of resources for each method and
sample (mean values).
Nonink Ink Ratio
nonink/ink
Ratio
ink/nonink
H-E levels 5.63 3.00 1.88 0.53
Immunohistochemistry 0.66 0.54 1.22 0.82
Block 6.00 2.00 3.00 0.33
Levels + immunohist. 6.29 3.54 1.78 0.56
was 600. The approximate cost of labor/reagents per
block/slide/immunohistochemical studies was $22,734.76.
3.2. Ink Method. The histopathologic diagnoses in 100
consecutive cases of transrectal prostate biopsies were the
following: benign prostate tissue 54%, PIN 8%, atypical
glands 4%, and adenocarcinoma 34%. A total of 600
initial histological examinations were carried out, and no
additional levels were required to make a diagnosis. Addi-
tionally, 54 immunohistochemical studies were performed
to conﬁrm the ﬁnal diagnosis. The total number of H-
E and immunohistochemical studies was 654. The total
number of paraﬃn blocks was 200. The approximate cost of
labor/reagents per block/slide/immunohistochemical study
was $11,109.43.
3.3. Correlation between Methods. A comparative study
between the nonink and ink method for histopathologic
diagnosis showed no statistical diﬀerences in the diagnostic
categories (P value <. 005) (Table 1). One interesting result
was that the ink method resulted in twice as many diagnoses
of PIN than the noninked method, but no statistical
diﬀerences were found. Table 2 shows the comparative use
of resource, and Table 3 shows that, for each test and case
studied by the nonink method, we required 0.53 levels,Prostate Cancer 3
0.82 immunohistochemical studies, and 0.33 paraﬃn blocks
using the ink method. The cost reduction was 48.86%.
4.Discussion
Although systematic parasagittal sextant biopsy has been
the standard protocol for many years, studies that use
extended protocols have shown that it misses 10–30% of
cancers [3, 6]. The ideal biopsy protocol still has to be
determined [7, 8]. There are not any established guidelines
for processing prostate biopsy specimens, and practices
vary considerably. Our study aims to determine which
histological procedure can be used with conﬁdence in the
general pathology laboratory. We have chosen to address this
questionusingtwodiﬀerentmethods:theﬁrstisatraditional
procedure used in routine pathology laboratories, while the
second—the ink method—consists of cylinders stained with
colored ink depending on prostate location and a speciﬁc
histopathologic protocol. Our results showed that the ink
method had the same diagnostic quality and gave the same
information about prostatic adenocarcinoma.
Using our protocol, the biopsies from the right and left
sideoftheprostateareplacedintwoparaﬃnblocksandthree
HEstaining sectionsofeachblockareobtainedfordiagnosis.
Inthisway,pathologyexpensesare cutbymorethan halfand
the information provided about location is the same. The
protocol also permits three immunohistochemical markers
when necessary, which presents no problems of the loss of
paraﬃn-embedded material.
Previous research has been carried out on the use of the
ink method for prostate biopsy [9, 10], and results show that
costscan bereducedwith thesame information abouttumor
location provided. However, this research focused only on
the speciﬁc location of the prostate specimen. In our study,
we used a speciﬁc histopathologic protocol coupled with the
ink method, and, in terms of diagnostic category, the results
were not diﬀerent from those of the traditional method.
Thedetectionofprostaticintraepithelial neoplasia increased,
probably because none of the material studied for diagnosis
was lost. On the other hand, when multiple prostate biopsy
cores are embedded in a single block, probably less tissue
is evaluated because it is diﬃcult to embed all cores in a
single plane for optimal tissue presentation [11]. However,
with properhandling, multiple cores percassette seems to be
reasonable. Finally, by reducing the number of blocks/slides
from six to two, the potential savings could be in hundreds
of million per year. Saving has also been shown when the
containers are reduced from 12 to 6 [12].
In conclusion, the application of tissue-marking ink in
prostate biopsies can prevent valuable information about
tumor location from being lost. The combination of the ink
methodandspeciﬁchistopathologicinformationreducesthe
time and cost of processing biopsies and can still guarantee
reliable results.
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